Zobrazeno 1 - 10
of 14
pro vyhledávání: '"N. M. Gonzalez"'
Autor:
T. Puig, L. Leache, N. M. González-Senac, E. Carreras, M. Gutiérrez-Valencia, L. Losa, J. L. Revuelta-Herrero, P. Marrero-Álvarez, M. de Miguel, A. Aguirrezabal Arredondo, A. Aranguren, A. Vilariño, V. E. Ruiz, I. Fernández, J. Bilbao, C. González-Guerrero, B. del Pino, N. Garin, on behalf of the MAPAC-MPC Network
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Purpose In recent years, the need for a more appropriate prescription of medications in the older population has emerged as a significant public health concern. In this study, we aimed to evaluate the prevalence of potentially inappropriate
Externí odkaz:
https://doaj.org/article/d6872b3f10f54b53bdc1bf4c6ec79f32
Publikováno v:
Tissue Antigens. 24:25-29
To investigate whether an association could be found between HLA and lepromatous leprosy a population study was performed in Tachira, Venezuela. This was done in the same endemic area in which recently both non-random parental HLA-haplotype and prefe
Publikováno v:
Psychopharmacology bulletin. 30(2)
This research measured naltrexone levels in plasma, to assess the relationship between behavioral response to naltrexone and plasma levels, and the effects of naltrexone on weight in hospitalized autistic children (n = 41). A double-blind, placebo-co
Publikováno v:
Journal of the American Academy of Child and Adolescent Psychiatry. 32(3)
It is essential to recognize individual susceptibility to neuroleptic-induced side effects for treatment guidelines. This paper reports on a 6.9-year-old autistic male who developed repeated episodes of acute dystonic reactions associated with pimozi
Publikováno v:
Psychopharmacology bulletin. 29(3)
The present study compared baseline assessments of 30 autistic children studied at ages 2.8 to 6.3 years (mean = 4.5; median = 4.5) with assessments at followup 0.38 to 14.3 years later (mean = 5.05; median = 4.33). The assessments included diagnosis
Publikováno v:
Psychopharmacology bulletin. 29(2)
Plasma beta-endorphin levels were measured in 13 autistic children, aged 3.67 to 11.67 years at the end of treatment (naltrexone, haloperidol, pimozide, or placebo) and in 5 of the 13 children also at baseline. Baseline plasma beta-endorphin levels w
Publikováno v:
The Psychiatric clinics of North America. 15(1)
Although this article focuses on psychopharmacology, pharmacotherapy is only part of a comprehensive treatment program. Treatment should be individualized to the patient's condition and level of intellectual functioning (e.g., conduct disorder, menta
Publikováno v:
Psychopharmacology bulletin. 28(2)
This open pilot study explored the efficacy and safety of pimozide, over a 3-week period, in hospitalized autistic children. Eight males, ages 4.2 to 8.3 years, completed the study. Intellectual functioning ranged from moderate to profound mental ret
Publikováno v:
Psychopharmacology bulletin. 27(3)
Data were pooled from three controlled and double-blind studies of lithium carbonate involving a total of 48 hospitalized children, and secondary data analyses were conducted. The objective was to assess whether there is a relationship between a chil
Publikováno v:
Journal of Infectious Diseases. 151:9-14
In a study of the relation between HLA and lepromatous leprosy, HLA haplotype segregation was analyzed in 28 families with multiple cases of different types of leprosy. The inheritance of HLA-DR2, HLA-DR3, and HLA-MT1, which had previously been shown